Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New COVID-19 treatment candidate TADIOS put to the test

NCT ID NCT05552625

First seen Oct 31, 2025 · Last updated May 19, 2026 · Updated 29 times

Summary

This study aimed to see if adding TADIOS to standard care helps people with mild to moderate COVID-19 recover faster and feel better. Researchers planned to measure inflammation markers, symptom improvement, and quality of life in hospitalized adults aged 18-65. However, the study was withdrawn before enrolling any participants, so no results are available.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Chaitanya Hospital

    Paravūr, Kerala, 683513, India

  • Gunjkar Multispeciality Hospital

    Pune, Maharashtra, 4110019, India

  • Lakshmi Nursing Home

    Kochi, Kerala, 683101, India

  • Oxycare Multispecialty Hospital

    Pune, Maharashtra, 411033, India

  • Sparsh Superspeciality Hospital

    Bangalore, Karnataka, 560022, India

  • Vagus Super Specialty Hospital

    Bangalore, Karnataka, 560003, India

Conditions

Explore the condition pages connected to this study.